Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia
Authors:
- Mirjam Christ-CrainMCMirjam Christ-Crain
- Thomas BregenzerTBThomas Bregenzer
- Martin KrauseMKMartin Krause
- Werner ZimmerliWZWerner Zimmerli
- Beat MuellerBMBeat Mueller
- Philipp SchuetzPSPhilipp Schuetz
- ProHOSP Study GroupPGProHOSP Study Group
Abstract
No abstract availableKeywords
Funding Information
- Swiss National Science Foundation ([SNF 3200BO-116177/1])
This publication has 30 references indexed in Scilit:
- Managing community-acquired pneumonia: A European perspectiveRespiratory Medicine, 2007
- Selective Use of Blood Cultures in Emergency Department Pneumonia PatientsThe Journal of Emergency Medicine, 2007
- Procalcitonin Guidance of Antibiotic Therapy in Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Guidelines for the management of adult lower respiratory tract infectionsEuropean Respiratory Journal, 2005
- Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired PneumoniaArchives of internal medicine (1960), 2004
- Predicting Bacteremia in Patients with Community-Acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2004
- The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired PneumoniaChest, 2003
- Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesThorax, 2001
- The influence of the severity of community-acquired pneumonia on the usefulness of blood culturesRespiratory Medicine, 2001
- The cost of treating community-acquired pneumoniaClinical Therapeutics, 1998